MBAL Trakia EOOD — Clinical Trial Site

16 Registered trials

7 Currently recruiting

Organisation

MBAL Trakia EOOD

Location

Stara Zagora, Bulgaria

Identifier

ORG-100047058

Address

Ulitsa Dunav 1, 6004, Bulgaria

Departments

Department - Medical Oncology Level III
Department - Medical Oncology Level III
Department – Medical Oncology Level III
Department of cardiology
Department of Eye Diseases
Department of Internal Medicine
Department of medical oncology
Ear, nose and throat Department
Eye disease
Eye diseases department
Ophthalmology Diseases Department

Clinical trials at this site (16)

Search interface

A clinical study to investigate the safety and tolerability of efimosfermin alfa injection in participants with known or suspected F2- or F3… Pending

2025-523674-16-00 Metabolic Dysfunction-Associated Steatohepatitis (MASH) 5
A pivotal clinical study to investigate the safety and efficacy of efimosfermin alfa injection in participants with biopsyconfirmed F2- or F… Pending

2025-523675-39-00 Metabolic Dysfunction-Associated Steatohepatitis (MASH) 5
A Study of Navlimetostat (BMS-986504) in Combination with Pembrolizumab Plus Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy… Recruiting

2025-521511-40-00 metastatic non-small cell lung cancer 10 2025-11-18
HF-POLARIS: A research study to look at how well NNC0487-0111 works compared to placebo in people with heart failure and obesity Recruiting

2025-523717-29-00 HFpEF or HFmrEF and obesity 5 2026-04-28
Clinical Study to Compare Efficacy and Safety of AVT29 and Eylea HD in Participants with Diabetic Macular Edema Recruiting

2025-522231-34-00 Diabetic Macular Edema 5 2026-03-31
A multi-center evaluation of NGM120 in a randomized, double-blind, placebo-controlled study in participants with colorectal cancer who have … Recruiting

2025-521730-28-00 Colorectal Cancer with Cancer Cachexia 4 2026-03-30
A Phase 3, Randomized, Double-Masked, Active-Controlled Trial of a Single Intravitreal Injection of 4D-150 in Adults with Macular Neovascula… Recruiting

2025-521349-25-00 Macular neovascularization secondary to age-related mac 5 2025-12-09
A Study to Learn About the Study Medicine Called PF-08046054/SGNPDL1V Versus Docetaxel in Adult Participants with Previously-treated Program… Recruiting

2025-521281-97-00 Non-Small Cell Lung Cancer (NSCLC) 5 2025-12-02
Study of Adagrasib plus Pembrolizumab plus Chemotherapy vs. Placebo plus Pembrolizumab plus Chemotherapy in Participants with Previously Unt… Recruiting

2024-515698-85-00 Locally Advanced or Metastatic Non-small Cell Lung Canc 5 2025-06-12
A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer Ended

2024-511038-11-00 advanced prostate cancer 4 2024-09-24
A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) Ended

2022-502481-24-00 Chronic Rhinosinusitis without Nasal Polyps (CRSsNP) 4 2024-05-23
A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolis… Ended

2023-503794-38-00 Prevention of stroke or systemic embolism in atrial fib 5 2022-11-24
A clinical study of OPT-302 with aflibercept compared to aflibercept alone in patients with neovascular age-related macular degeneration Ended

2024-512880-30-00 Neovascular Age-related Macular Degeneration (wet AMD) 5 2021-08-27
A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants with Open-Angle Glaucoma or Ocular Hypertension Ended

2022-502380-37-00 Open-Angle Glaucoma 5 2019-08-02
A Phase 3 Double-masked, Randomized, Multicenter Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edem… Ended

2023-507207-66-00 Diabetic Macular Edema (DME) 5
A Clinical Trial to compare Efficacy, Safety, Tolerability of RBS-001 to Eylea® in Subjects with Neovascular Age-Related Macular Degeneratio… Ended

2023-509206-29-00 Neovascular age-related macular degeneration (nAMD) 5